July 6, 2020— The first half of 2020 has been a challenging time for our nation and for covered entities participating in the 340B drug pricing program. Hospitals, health centers, and clinics have spent most of the year mobilizing their COVID-19 responses while continuing to work tirelessly to care for underserved patients with a variety of chronic and acute medical … [Read more...]